Figure 1D showed that the level of LSD1 is significantly elevated in high-grade and metastatic cancers. More importantly, patients with elevated levels of LSD1 in their BCa (Figure 1E) also have shortened overall survival (Figure 1F). Here, KDM1A is linked to metastatic malignant neoplasm.